Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
Clinical trial NCT05555732 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05555732
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-11
- Primary completion
- 2029-05-11
- Enrollment
- 1170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.